FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

Official launch of the New Zealand Multiple Sclerosis Research Trust




























Aukland New Zeland
Image source: KIWITOPIA

Media release from New Zealand Multiple Sclerosis Research Trust

$900,000 in grants kick starts trust dedicated to New Zealand-based Multiple Sclerosis research

The New Zealand Multiple Sclerosis Research Trust (NZMSRT) today announces it has received a combined $900,000 investment portfolio as founding capital for the Trust.

A $600,000 portfolio has been transferred from the Multiple Sclerosis Society of New Zealand and a $300,000 portfolio from the Multiple Sclerosis Auckland Region Trust.

The Research Trust has been established to stimulate, co-ordinate and support New Zealand-based research into the cause, prevention, treatment, alleviation and cure of Multiple Sclerosis (MS), and to obtain and disseminate research findings.

NZMSRT Trustee Neil Woodhams said: “We are delighted to have secured this substantial initial funding. This is an important first step to securing much needed capital for the many New Zealand-based MS research projects that need our help.

With the Trust now established, we will be looking at further opportunities to increase the capital base of the Trust.”

The Trust has a target of raising a minimum of $5 million in the next 5 years and will use income generated from its investments to collaborate with partners to fund research that improves the lives of people with MS.

With the rate of MS on the increase in New Zealand, there is a need to centralise the autonomous research being undertaken by numerous different organisations throughout the country.

“A single point of focus is needed for funding MS research. In the past, in many cases research for MS has been one of only a number of research strands within organisations that deal with a wide range of neurological or other health conditions,” Mr Woodhams said.

Because of its size, geographic spread of population and the ability through the health system to accurately track individuals, New Zealand provides an ideal environment for MS research. Recent research has revealed that the incidence of MS for people living in Otago and Southland is four times that of people living in Auckland or Northland.

According to figures from the 2006 New Zealand National MS Prevalence Study, 2,917 people have been diagnosed with MS in New Zealand with the female to male ratio of illness at 3:1. The number of people with MS has continued to grow since then due to the number of new cases being diagnosed every year.

The Trust is registered under the Charitable Trusts Act.


About New Zealand Multiple Sclerosis Research Trust:

The New Zealand Multiple Sclerosis Research Trust was established for the purpose of stimulating, co-ordinating and supporting New Zealand-based research into the cause,

prevention, treatment, alleviation and cure of Multiple Sclerosis (MS), and to obtain and disseminate research findings. Registered under the Charitable Trusts Act, the NZ MS

Research Trust collaborates with partners to fund research that helps people with MS, informs people about research findings and uses fact-based research findings to improve the lives of people with MS. See: www.msresearch.nz

Story Source: The above story is based on materials provided by NZDOCTOR
Note: Materials may be edited for content and length


Go to Newer News Go to Older News